Skip to content

the Effect of Endometrial Compaction Caused by Progesterone Effect on Pregnancy Outcomes

The Effect of Progesterone Induced Endometrial Compaction on Pregnancy Outcomes in Frozen-thawed Embryo Transfer at the Blastocyst Stage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04733235
Enrollment
205
Registered
2021-02-02
Start date
2020-07-01
Completion date
2021-07-15
Last updated
2023-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility, Frozen-thawed Embryo Transfer, Infertility

Keywords

infertility, female infertility, frozen- thawed embryo transfer, female

Brief summary

The purpose of this prospective cohort study is to assess the effect of endometrial compaction caused by progesterone effect on pregnancy outcomes

Detailed description

For a pregnancy to occur, the embryo must implant in a receptive endometrium during the window of implantation, which is thought to occur from day 22 to 24 of an idealized 28-day cycle. Early studies have suggested that assessing endometrial thickness with the use of ultrasound may be an alternative to invasive techniques such as endometrial biopsy for attempting to determine a receptive endometrium for frozen-thawed embryo transfer (FET). A preovulatory endometrial thickness of 7 mm or more is considered to be the cutoff for endometrial receptivity, below which many physicians would cancel an embryo transfer. However, in most studies in the literature, endometrial thickness was measured either on the day of hCG in fresh embryo transfer cases or on the last day of estrogen treatment in thawed embryo transfers. There are a limited number of studies evaluating the luteal period, embryo transfer day and endometrial thickness. Accordingly, in this prospective cohort study is to assess the effect of endometrial compaction caused by progesterone effect on pregnancy outcomes

Interventions

DRUGProgesterone

ultrasound measurements of endometrial thickness at the end of the estrogen phase and the day of embryo transfer.

Sponsors

Akdeniz University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Woman aged 18-40 years 2. Presence of high quality (\>2BB) blastocyst 3. Hormonal(estrogen and progesterone) frozen- thawed embryo transfer cycles 4. presence of high quality blastocyst cryopreserved by vitrification method. 5. A single embryo transfer

Exclusion criteria

1. Presence of uterine pathology 2. Participants whose optimal endometrial image cannot be obtained due to uterine position 3. Participants whose treatments were canceled for any reason before embryo transfer 4. Participants which had embryo transfer on the day 2 or 3 (at the cleavage stage) 5. Participants who had 2 embryo transfer 6. Presence of low quality (\<2BB) blastocyst 7. \> 15% loss of viability in the embryo during embryo thawing

Design outcomes

Primary

MeasureTime frameDescription
The change in endometrial thickness1 yearchanging in millimeters of endometrial thickness at the end of the estrogen phase and the day of embryo transfer.
ongoing pregnancy rates.1 yearpregnancy beyond 12 weeks of gestational age.

Secondary

MeasureTime frameDescription
The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo TransferOn the day of frozen embryo transfercomparison of progesterone levels and endometrial thickness
Clinical pregnancy rate6-7 weeks after the last menstrual period of the patient6th week gestational age
Implantation rate5 weeks after the last menstrual period of the patientPercentage of gestational sacs compared to the number of embryos transferred
Clinical miscarriageafter 5th gestational weekpregnancy loss after ultrasonographic detection of an intrauterine gestational sac

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026